Company Portfolio
Massachusetts Institute of Technology
Portfolio strength
Strong portfolio
Patents indexed
8
Year range
1983 – 2025
Patent Activity by Year
All Patents
8
Career timeline
6 patents, 1983–2025
Dot size = forward citations
Hover or tap any dot to see the patent. Larger dots indicate more forward citations — a proxy for downstream influence.
How to Edit Genes in Human Cells Using an Engineered CRISPR System
This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.
How RSA Public-Key Encryption Keeps Digital Messages Secret
This patent describes the foundational RSA algorithm, a method for securely sending messages where anyone can encrypt a message using a public key, but only the intended recipient can decrypt it using a secret private key.
Tiny Capsules for Electronic Paper Displays
MIT's 1999 patent on a special ink made of tiny capsules that can change color when an electric field is applied, forming the basis for early e-readers.
Delivering Large Gene Editing Tools into Cells with Hybrid Virus-Lipid Packages
This patent describes a sophisticated delivery system that combines parts of a virus with a fat bubble (liposome) to efficiently transport large molecules, like CRISPR gene-editing components, into specific cells.
Combining Radio Signals Efficiently with Special Wires
MIT's 2015 patent describes a clever way to combine multiple radio signals using specific lengths of transmission lines to boost power efficiently and linearly.
How to Make Animals That Can Turn On CRISPR Gene Editing
This patent describes creating genetically modified non-human animals, like mice, where a key CRISPR gene-editing protein (Cas9) can be turned on only in specific cells or at specific times using a special genetic switch.
Highly Efficient Bacterial Gene Editing Using Guide RNA and Reverse Transcriptase
This patent describes a system for precisely editing the DNA of bacterial cells with very high success rates, using a combination of guide RNA, reverse transcriptase, and specific DNA sequences.
How Special Molecules Boost Cancer-Fighting CAR-T Cells
This patent describes special molecules made of a CAR-T cell activator attached to a fat-like part, designed to make cancer-fighting CAR-T cells grow and work better inside a patient.
Patent monitoring